Collectively, these findings identify UPP1 as a key regulator of epithelial reprogramming and IM, linking H. pylori-driven inflammation with WNT-mediated differentiation, and highlight its potential as a prognostic biomarker and therapeutic target in GC. Here, UPP1 is linked to gastric cancer.